These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36830314)

  • 21. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
    Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
    J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics and prognostic risk factors analysis of carbapenem-resistant organism in the department of hematology].
    Chen SZ; Xu JJ; Xiao TT; Weng YX; Chen DB; Zhang Y; Ren JH; Luo XF; Zheng ZH; Zheng XY; Chen ZZ; Hu JD; Yang T
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):563-569. PubMed ID: 34455743
    [No Abstract]   [Full Text] [Related]  

  • 24. Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae: A Menace to Highly Vulnerable Patients.
    Kumar A; Mohapatra S; Bakhshi S; Mahapatra M; Sreenivas V; Das BK; Sood S; Kapil A
    J Glob Infect Dis; 2018; 10(4):218-221. PubMed ID: 30581264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization.
    Chen X; Wen X; Jiang Z; Yan Q
    Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):3. PubMed ID: 36627626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
    Nirmal G; Jithin TK; Gopakumar KG; Parthiban R; Nair C
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e678-e682. PubMed ID: 37146155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream Infections Caused by Carbapenem-Resistant
    Zhou C; Jin L; Wang Q; Wang X; Chen F; Gao Y; Zhao C; Chen H; Cao B; Wang H
    Infect Drug Resist; 2021; 14():731-742. PubMed ID: 33658810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
    Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
    Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
    Alrstom A; Alsuliman T; Daher N; Abouharb R
    Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
    Yang TT; Luo XP; Yang Q; Chen HC; Luo Y; Zhao YM; Ye YS; Lai XY; Yu J; Tan YM; Wei GQ; Huang H; Shi JM
    Antimicrob Resist Infect Control; 2020 Mar; 9(1):49. PubMed ID: 32183898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
    Tian F; Li Y; Wang Y; Yu B; Song J; Ning Q; Jian C; Ni M
    Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):10. PubMed ID: 36710337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of
    Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
    Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae.
    Gao B; Li X; Yang F; Chen W; Zhao Y; Bai G; Zhang Z
    Front Pharmacol; 2019; 10():262. PubMed ID: 30967778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.